Sangamo Therapeutics, Inc.
SGMO
$0.15
-$0.02-12.73%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.17% | -7.13% | -74.77% | 34.68% | -30.78% |
| Total Depreciation and Amortization | -53.43% | -0.79% | 0.05% | -1.40% | -9.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.54% | 622.24% | -5.72% | -13.26% | 31.50% |
| Change in Net Operating Assets | 332.77% | -275.70% | 203.53% | -2,919.48% | -100.48% |
| Cash from Operations | 20.99% | 14.37% | -56.94% | 30.56% | -680.33% |
| Capital Expenditure | 7.14% | 78.13% | -166.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 7.14% | 78.13% | -166.67% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 78.78% | -22.21% | -32.94% | 180.22% | 43.68% |
| Repurchase of Common Stock | -8.60% | -30.71% | 36.43% | 81.14% | -912.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 80.44% | -22.95% | -32.89% | 251.78% | 16.35% |
| Foreign Exchange rate Adjustments | -2,015.00% | -4.76% | -98.46% | 113.94% | 156.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 169.29% | -2.83% | -170.77% | 178.65% | -716.05% |